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Abstract
Background: To describe the optical coherence tomography angiograhy (OCTA) of drusenoid pigment epithelial
detachments (PEDs) in a woman affected by Complement 3 (C3) glomerulopathy, which represents a spectrum of
glomerular diseases characterized on fluorescent microscopy by C3 accumulation with absent, or scanty,
immunoglobulin deposits. It is due to acquired or genetically defective alternative pathway control and is generally
associated with drusen-like deposits in Bruch’s membrane, as well as choriocapillaris. These retinal lesions can be
associated with choroidal neovascularization and central serous chorioretinopathy (CSCR). OCTA is useful to detect
neovascularization without injecting a contrast product, particularly in these patients who may have renal
insufficiency.
Case presentation: A 28-year-old woman affected by C3 glomerulpathy was diagnosed with asymptomatic multiple
bilateral PEDs during a routine ophthalmologic consultation. To better characterize the lesions, multimodal imaging
was performed and included: optic coherence tomography (OCT), en-face OCT, OCTA, fluorescence and indocyanine
angiography. The OCTA clearly identified vascular network rarefaction with decreased choriocapillary vascularization. It
confirmed that PEDs associated with C3 glomerulonephritis are not vascularized, but rather of serous type.
Conclusions: Patients affected by C3 glomerulopathy can develop neovascular membranes as retinal complications of
pigment epithelial detachments. Optical coherence angiography may be indicated to identify this complication,
without injecting any contrast product that could produce further kidney damage.
Keywords: Complement 3 glomerulopathy, Drusenoid pigment epithelial detachments, Alternative pathway,
Multimodal imaging, Optic coherence tomography angiography, Choroidal neovascularization
Background
Complement 3 (C3) glomerulopathy is a rare group of
glomerular diseases. Presenting features include protein-
uria, sometimes with nephrotic syndrome, hematuria,
hypertension and renal failure. It mostly affects older
children, adolescents and young adults. It is character-
ized by C3 deposits in the mesangium and along the
glomerular basement membrane (GBM). In some pa-
tients, C3 glomerulopathy can be associated with retinal
lesions described as drusen-like deposits in Bruch’s
membrane and choriocapillaris. Thickening of GBM
along with glomerular proliferative lesions induce
impairment of glomerular filtration, hematuria, protein-
uria and at end stage a loss of renal function. In the eye,
thickening of Bruch’s membrane and subendothelial/
subepithelial deposits induce the formation of drusen,
predisposing to a risk of decreased vision [1, 2].
We present a patient with C3 glomerulopathy associ-
ated with retinal lesions, and report multimodal imaging
findings. We also report a review of the literature of
published cases of patients with C3 glomerulopathy
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associated with retinal findings, with a special focus on
imaging studies.
Case presentation
A 28-year-old female, known to have C3 glomerulopa-
thy, presented to our clinic for a routine check-up and
was found to have asymptomatic multiple bilateral
retinal pigment epithelium detachments (PEDs). At
twelve years of age, the patient suffered a nephrotic
syndrome,and a first renal biopsy revealed diffuse mem-
branoproliferative glomerulonephritis (MPGN). This was
treated with oral corticosteroids and cyclophosphamide
and was maintained on azathioprine. Relapse occurred
after a five-year period of remission, and a new renal
biopsy showed a membranoproliferative glomeruloneph-
ritis of type I (MPGNI). Immunofluorescence assay was
positive for deposits of C3 complement, and the diagno-
sis of C3 glomerulonephritis (C3GN) was confirmed.
The electronic microscopy of a glomerulus showed that
the deposits were localized in a subendothelial manner,
as typically seen in C3 Glomerulonephritis C3GN
(former MPGN type 1). (Figure 1). Secondary causes of
C3GN were excluded by a complete workup: hepatitis B
and C serology, cryoglobulinemia, absence of monoclo-
nal gammapathy on serum electrophoresis. Complemen-
tary exploration in the serum confirmed an activation of
the alternative pathway: C3 low at 0.23 g/l (n: 0.75–1.4),
C4 normal at 0.26 g/l (n: 0.10–0.34), C5B9 elevated at
551.4 ng/ml (n: 127–303) and CH50 at 23% (n: 70–
140%). Genetic and acquired autoantibodies (C3 neph-
ritic factor, anti-factor H antibodies) investigations were
negative. Treatment with low-dose cyclosporine resulted
in stabilization of the disease for a further 5 years. At
this point multiple relapses occurred with recurrence of
proteinuria and decrease in renal function, treated with
cyclosporine, followed by intravenous IV Rituximab.
Despite the use of immunosuppressant drugs, protein-
uria progressively worsened and renal function deterio-
rated. Peritoneal dialysis was started 1 year ago and the
patient is currently evaluated for a renal graft. She is also
on acenocoumarol for a factor V Leiden.
At presentation, the patient had a routine ophthalmo-
logic examination: best corrected visual acuity was 12/10
in both eyes, bilateral anterior segment examination was
unremarkable, eye pressure was normal in both eyes.
Fundus examination revealed more than 50 yellowish
subepithelial drusen-like elevations in macula, mid-
periphery and periphery of both eyes. Spectral domain
optical coherence tomography (SD OCT) showed that
these lesions were PEDs with serous content (Fig. 2).
Choroidal thickness evaluated by enhanced depth OCT
was 328 μm in the right eye and 271 μm in the left eye.
En-face OCT showed PED at different regions of the
retina and clearly localized the deposits between the sube-
pithelial space and the external limiting membrane (Fig. 3).
Fluorescence angiography (FA) revealed hyperfluorescent
well circumscribed lesions in a greater number than those
observed in the fundus on early and late time frames, with
no evidence of leakage. Indocyanine angiography showed
late hypercyanescence of the retinal lesions in both eyes
(Fig. 4). Optical coherence angiography (OCTA) of the
superficial and deep capillary plexuses revealed no abnor-
malities. OCTA of the outer retina and choriocapillaris
layers did not show any abnormal vascular membranes
associated with PEDs, but vascular network rarefaction
was clearly identified with fewer blood vessels in the
choriocapillaris layer (Fig. 5). OCT angiography (OCTA)
confirmed that PEDs associated with C3 glomeruloneph-
ritis were not vascularized but rather of serous type.
Vascular abnormalities seen in the choriocapillaris layer
may play a role in the pathogenesis, or simply represent a
consequence of material accumulation in PED associated
with C3 glomerulonephritis.
The patient was followed regularly in our department.
At her last follow up visit (2 years after presentation),
she presented asymptomatic bilateral papillary edema
(Fig. 6). Visual acuity was still 12/10 in both eyes, color
vision (Ishihara pseudoisochromatic chart) was normal
in both eyes, visual field was normal in right eye but
showed small superior defects in the left eye. Anterior
biomicroscopy was normal and bilateral PEDs remained
present. Retinal nerve fiber layer thickness in the peripa-
pillary area was increased: 248 μm in the right eye, and
264 μm in the left eye. Cerebral magnetic resonance
imaging (MRI) was performed and revealed primary
intracranial hypertension, for which she was referred to
the neurosurgeons.
Fig. 1 Electronic microscopy of a glomerulus shows the deposits
localized in a subendothelial manner, as typically seen in C3
Glomerulonephritis C3GN (former MPGN type 1). * Podocyte foot
process and ** Subendothelial deposit. Image kindly provided by
Samuel Rotman MD pathology department CHUV)
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Discussion and conclusions
In the past, classification of membranoproliferative
glomerulopathy (MPGN) was based on pathological
findings of electron microscopy, and 3 types of MPGN
were described: type I is characterized by subendothelial
deposits, type II or dense deposit disease (DDD) by
glomerular basement membrane dense deposits, and
type III by both subepithelial and subendothelial
deposits [3]. Recently, a new classification has been
proposed based on immunofluorescence microscopy:
immune complex-mediated glomerulonephritis and
complement-mediated glomerulonephritis [1, 4]. The
new classification is more appropriate as it better reflects
the underlying pathophysiology of the disease.
MPGN types I and III have been reclassified in
complement 3 glomerulonephritis (C3GN), characterized
by discrete deposits in the mesangium, and subendothelial
and subepithelial capillary walls. MPGN II and C3GN are
complement-mediated glomerular disease and are part of
C3 glomerulopathies, these characterized by complement
3 deposits with absent or scant immunoglobulin deposits
on fluorescent microscopy. C3 glomerulopathies represent
a spectrum of glomerular diseases due to defective alter-
native pathway control [1, 2]. The alternative pathway
recognizes and eliminates microbes or modified cells. It is
now recognized that not only MPGN II, but also C3GN,
can be accompanied by retinal drusen.
The choriocapillaris-Bruch membrane-retinal pigment
epithelium (RPE) interface is anatomically similar to the
capillary tuft-GBM-glomerular epithelial interface [5].
These organs lack local membrane-bound complement
regulators, thus they are vulnerable to injury caused by
products of uncontrolled alternative pathway. Deposits
in retina and kidney have the same structure and
composition [6].
Drusen are defined as deposits within Bruch’s
membrane and are a hallmark feature of age-related
macular degeneration (AMD). These lesions have
been largely described in MPGN type II since 1989
[5–20], but the first description of drusen in MPGN
type I was given in 2009 [21]. In a case report, Han
et al. reported the presence of multiple “drusens” and
“PEDs”. In 2001, Mullins et al. analyzed the structure
and composition of drusen in MPGN and in post-
streptococcal GN, and compared them with drusen in
AMD. They found that the drusen have a similar
composition in both types of membranous GN and in
AMD: vitronectin (inhibitor of complement), comple-
ment C5, complement C5b-9, TIMP-3, amyloid P, and
lipids. It was not specified whether MPGN was of
type I or type II, but material within the drusen was
electron-dense and electron-lucent [22]. The lesions
observed in our patient were completely transluscent
on OCT, representing serous PEDs. In the literature,
various lesions such as drusen, PEDs, drusenoid PEDs
were reported in patients with C3GN [21, 22]. These
lesions may represent a continuum of the same phato-
physiologic process involving the accumulation of material
in the subretinal space. This may result in a decrease of
retinal function, as revealed by abnormally lower elecro-
retinography responses and reduced sensitivity in areas of
high density.
MPGN II can be associated with choroidal neovasculari-
zation and central serous chorioretinopathy (CSCR)-like
findings [9, 23–27]. As MPGN I and II are part of a
spectrum of the same C3 glomerulopathies, patients with
Fig. 2 a. RE IR photography. b. RE OCT section performed through drusen. c. LE IR photography. d. LE OCT section performed through drusen.
Multiple PEDs with serous content are visible on OCT
Fig. 3 a and (b): RE Enface OCT at the external limiting membrane
level. c and (d): RE Enface OCT at the RPE level. The deposits extend
between the subepithelial space and external limiting membrane
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either type of disease should be regularly checked in order
to identify and prevent ophthalmologic complications.
Various retinal imaging studies have been described
in patients affected by C3 glomerulopathy. First of all,
SD OCT is useful on a routine basis for all patients
with retinal disease. It helps to define exactly which
layers of the retina are affected by the disease, and al-
lows the diagnosis of any secondary complication
(choroidal neovascularization, CNV or atrophy). In
the literature, many structural alterations in outer ret-
inal layers and RPE were reported in patients with C3
glomerulopathy: irregularities in RPE surface, lucent
or tent-shaped RPE detachments or elevations, sub-
RPE drusenoid deposits, areas of compression of the
photoreceptor layer, missing inner segments/outer
segments IS/OS and external limiting membrane ELM
back-reflection [1, 2, 11, 26, 28]. A prototype high-
speed ultrahigh optic coherence tomography (UHR-
OCT) with an axial resolution of approximately 3 μm
in tissue was realized in the left eye of a 29-year-old
man, affected by drusen-like deposits in the context
of C3 glomerulopathy. The UHR-OCT showed not
Fig. 4 a and b: RE fluorescein angiography shows hyperfluorescent well circumscribed lesions on early and late time frames. c and d: RE
indocyanine angiography at early and late phase: late hypercyanescence of the retinal lesions in both eyes
Fig. 5 LE OCT angiography (OCTA). a and (b): In the superficial and deep capillary plexus: no abnormalities. c and (d): In the outer retina and
choriocapillaris layers: no vascular membranes associated with PEDs, but rarefaction of vascular network, with a decrease of blood vessels in the
choriocapillaris layer
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only RPE detachment, but also an irregular and
prominent Bruch’s membrane measuring between 9
and 13 μm at 3 locations, compared to that of
healthy patients being between 2 and 4.7 μm. It
seems to be an interesting tool, because it permits
the delineation of Bruch’s membrane from RPE, which
is not possible with the commercially available SD-
OCT that has an axial resolution in tissue of 5 to
7 μm [9].
Another useful exam is fluorescein and indocyanine
green angiography. Drusen without any complications
have been described as having a starry sky appearance
on fluorescein angiography [2]. Early phase typically
shows window defects due to basal lamina drusen,
and late phases typically show staining of hyperfluor-
escence with no evidence of fluid leakage [1, 7, 13,
21, 29, 30]. Indocyanine green angiography helps in
excluding or identifying choroidal neovascular mem-
branes or CSCR-like lesions as possible complications
[9, 21]. Fluorescein angiograms may show normal re-
sults, while penetrating ratios detected by vitreous
fluorophotometry readings can be abnormally high, as
demonstrated by Raines et al. in 1989. This indicates
a breakdown of the blood retinal barrier as a conse-
quence of retinal pigment epithelium dysfunction due
to Bruch’s membrane deposits [17]. This imaging
technique is not, however, used on a routine basis.
Other authors reported microperimetry results, and
showed that eyes of patients with C3 glomerulopathy
may have reduced sensitivity in areas of high drusen
density, probably indicating areas of reduced retinal
function [13, 28].
Electophysiologic tests can also provide information
about retinal function. Leys et al. reported electro-
oculogram (EOG) results to be normal in patients
without choroidal neovascularization and abnormal in
patients with choroidal neovascularization (reduced light
peak/dark peak) on EOG [20]. Contrary to this, C
O’Brien et al. reported 3 asymptomatic patients with
typical drusen-like lesions seen in the posterior pole,
who had abnormally low Arden ratios on EOG but nor-
mal elecro-retinography responses (PERG, Flash-ERG,
Flicker ERG). This was the first report of choriocapillaris
and Bruch’s membrane disease causing electroculo-
graphic abnormality without any visual deficit [31]. Lah-
bil et al. also reported a case of bilateral retinal drusen
in a context of C3 glomerulopathy where the ERG was
normal [30]. In the presence of retinal complications
such as widespread chorioretinal atrophy, EOG, ERG,
multifocal ERG and dark adaptation can all show abnor-
malities [2, 32].
Fluorescein angiography is a useful diagnostic test,
but requires injection of fluorescein dye that can be
contraindicated in patients with advanced kidney
disease. Table 1 resumes the exams used by previous
authors to describe drusen. We highlight in this paper
the possibility of using OCT angiography in these
patients. This is a new retinal imaging technique that
allows analysis of the retinal plexuses and choroidal
vessels without injecting any dye, and can also
identify neovascular membranes. To our knowledge
this is the first report of OCTA of multifocal PEDs
associated with C3 glomerulopathy.
PEDs in MPGN have been shown to spontaneously
resolve [29], but generally the longer the renal disease is
present, the greater their evolution, becoming more
numerous with later atrophic changes [12, 15, 16]. Sub-
retinal membranes, macular detachment and central
serous retinopathy may occur. Some treatments, such as
corticosteroids, immunosuppressants and plasmapher-
esis have been used in these patients to treat the renal
disease, but they did not improve the retinal condition.
Recently, a newer drug was used in C3 glomerulopathy
[intravenous eculizumab (monoclonal antibody that
inhibits C5 and prevents formation of the C5b-9 mem-
brane attack complex)] and resulted in substantial
improvement of proteinuria, but it had no effect on
retinal accumulation of cascade degradation products.
In patients with C3 glomerulopathy, regular
ophthalmologic examination should be carried out in
order to identify retinal complications early in their
development. For patients having undergone a renal
graft, ophthalmologic follow-up should be continued
as the disease has been reported to recur in these
cases [33].
Multimodal imaging of retina with OCT and OCT
angiography could be useful in patients with C3
glomerulopathy, to help to identify early retinal manifes-
tations of the disease and enable diagnosis of possible
complications at an earlier stage. These patients may
develop neovascular membranes, so OCTA appears to
be a useful exam to identify this complication without
the need to use contrast products that could affect renal
function. Considering the progression of retinopathy and
potential retinal complications in C3 glomerulopathies,
close ophthalmologic follow-up is recommended, even
after a renal graft.
Fig. 6 a. RE fundus. b. LE fundus. Bilateral papillary edema and bilateral
multiple PEDs
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Table 1 This table resumes the exams used by previous authors to describe retinal drusen
Authors,
Journal (Year of publication)
Number
of cases
Symptoms Clinical findings Imaging Findings Lesions
Savige J et al., Ophthalmic
Genet (2016)
6 visual acuity normal or
near normal initially. First
symptom: impaired night
vision, progression to loss
of peripheral vision
bilateral symmetrical drusen. 2
types: 1. basal laminar drusen =
small, numerous, yellow. 2. large
soft whitish-yellow. Retinal
atrophy after 15 years and
choroidal neovascularization
OCT: irregularities in RPE surface,
RPE detachments, neovascular
membranes. Fluorescein angiography:
starry sky appearance of druse, multiple
small hyperfluorescent spots throughout
retina and complications. Amsler
grid:distorsion with late complications
multifocal ERG: lower amplitudes and
lower peak amplitude with retinal atrophy
typical drusen,
PED, CNV and
atrophy
Dalvin LA et al., Retin Cases
Brief Rep (2016)
2 1. VA 20/300 in both
eyes with eccentric
fixation2. VA 20/20 in
both eyes
peripheral drusen, subretinal
and RPE fibrosis, RPE
hypertrophy, scarring
OCT: drusen Fluorescein angiography:
areas of hypofluorescence corresponding
to subretinal fibrosis surrounded by leakage,
window defects, andmultiple drusen
typical drusen,
subretinal fibrosis
Adhi M et al., Ophthalmic
Surg Lasers Imaging Retina
(2014)
1 progressive loss of vision
secondary to CNV in RE,
and new distorsion of
vision in the LE
hemorrhage and subretinal
fluid superonasal to the macula
OCT: RPE detachment, irregular and
prominent Bruch’s membrane ICG
angiography: no definitive signs of CNV
PED, suspicion of
CNV
Empeslidis T et al., Case
Rep Ophthalmol Med
(2012)
1 problems with near vision
tasks
signs consistent with RPE
detachments and small
drusen-like lesions
OCT: PEDs, intraretinal fluid in a cystoid
form of less than 50um in the inner
retinal layers. No subretinal fluidFluorescein
angiography: early phase: window defect
due to basal lamina drusen; late phase:
staining of hyperfluorescence. No leakage.
RPE layer intact.
typical drusen.
PED, intraretinal
fluid with no
subretinal fluid.
No CNV
Ritter M et al., Br J
Ophthalmol (2010)
3 VA normal or slightly
reduced
drusen: temporal in early
cases, and throughout
the retina in advanced cases
OCT: RPE elevations, areas of compression
of the photoreceptor layer missing of IS/OS
and ELM backreflection Microperimetry:
reduced sensitivity in areas of high drusen
density
typical drusen
Han et al., Arch Ophthalmol
(2009)
1 VA normal in LE, and 20/
30 in RE
bilateral multifocal, 200-300um
yellowish lesions at choroid
and subretinal pigment
epithelial level
OCT: lucent focal elevations of RPE
Fluorescein and indocyanine Angiography:
staining of lesions throughout the fundi,
more numerous than those observed by
ophthalmoscopy
typical drusen
Amer Awan M et al., Clin
Exp Optom (2008)
1 blurring vision, micropsia,
metamorphopsia
elevated area overlying the
macula in both eyes. Multiple
pale areas without any drusen.
Peripheral retina normal in
both eyes.
OCT: tent-shaped RPE detachment with
overlying detachment of neurosensory
retina and loss of foveolar contour
Fluorescein Angiography: early multiple
hyperfluorescence areas corresponding
to these pale areas. Mid-phase leakage
of dye in subretinal space
atypical idiopathic
serous central
chorioretinopathy
with spontaneous
resolution at 6
weeks
Shenoy R et al., Eur J
Ophthalmol (2006)
1 asymptomatic multiple drusen-like lesions Microperimetry: areas of reduced retinal
sensitivity in areas which were laden with
drusen-like deposits, probably indicating
areas of reduced retinal function OCT:
drusen Fluorescein Angiography: multiple
window defects in the posterior pole of
both eyes corresponding to the drusen-like
lesions
typical drusen
Colville D et al., Am J
Kidney Dis (2003)
1 poor night vision,
complications resulted in
severe visual loss
occasional drusen, widespread
chorioretinal atrophy, macular
pigmentation
dark adaption test: uniphasic- > consistent
with severe rod dysfunction ERG: delayed
rod and delayed combined rod and cone
responses EOG: reduced light peak/dark
through (or Arden ratio) possibly reflecting
an ocbstruction to the passage of metabolites
from the choriocapillaris Fluorescein angiography:
subfoveal choroidal neovascularization
drusen, CNV and
atrophy
Lahbil D et al., J Fr
Ophtalmol (2002)
1 important decrease of
visual acuity in both eyes
diffuse punctiform yellow
subretinal lesions and
central serous detachment
in both eyes
Fluorescein Angiography: after
resorbtion of serous fluid, punctiform
hyperfluorescent lesions still staining
at late phase. ERG:normal
CRSC- like lesion
Mullins RF et al., Eye (2001) 2 numerous subretinal RPE
deposits similar to drusen
seen in AMD
histochemistry/ immunohistochemistry: same
composition of drusen in AMD
typical drusen
Polk T et al., Arch
ophthalmol (1997)
1 blurred vision in right
eye, with visual acuity
20/20 in RE, and 20/200
in LE
fine drusen in both eyes.
Neurosensory detachment in
the nasal macula of RE, and
disciform scar in LE
Fluorescein agiography: multiple
discrete hyperfluorescent spots
corresponding to drusen, and early
and late staining at RPE level in the
area of the detachment, with 4
neurosensory
detachment with
spontaneous
resolution at 2
weeks
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